Biogen Inc (BIIB)

HEALTH CARE: PHARMACEUTICALS
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

225 BINNEY STREET CAMBRIDGE, MA 02142

Biogen Idec Inc. (Biogen Idec) is a global biotechnology company. The products of the Company include AVONEX, RITUXAN, TYSABRI and FUMADERM. The Company's products address diseases, such as multiple sclerosis (MS), non-Hodgkin's lymphoma (NHL), rheumatoid arthritis (RA), Crohn's disease (CD) and psoriasis. In addition to the marketed products, Biogen Idec has a number of product candidates in or near registrational stage development. It includes BG-12, Daclizumab, Fampridine, GA101, Humanized Anti-CD20 MAb (ocrelizumab), Lixiavaptan, Long-Acting rFactor IX and PEGylated interferon beta-1a. In December 2010, the Company and Neurimmune Holding AG announced that the Company had acquired a subsidiary of Neurimmune Holding AG.

Data based on most recent fiscal year report
Market Cap56.361 Billion Shares Outstanding211.5 Million Avg Volume2.34 Million
1-Yr BETA vs S&P TR Current Ratio2.34 Quick Ratio2.07
View SEC Filings from BIIB instead.
Q2 2019 All Institutions Hedge Funds 1
To trade BIIB now:
Filers who had this stock in their top 10: 14 7 (0.72%)
13F Filers holding this stock: 964 92 (9.5%)
Aggregate 13F shares on 06/30/2019: 158.741 Million 17.008 Million
Aggregate 13F shares on 03/31/2019: 169.911 Million 15.924 Million
Percent change: -6.57% 6.81%
Funds creating new positions: 81 14
Funds Adding to an existing position: 304 33
Funds closing out their position: 139 20
Funds reducing their position: 432 36
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding BIIB (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

375 total shares from 2 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

DEKKERS MARIJN E

  • Director
32,159 2019-08-20 0

WIGGINS MARK C

  • Director
0 2019-08-09 0

SCANGOS GEORGE A

  • Director
1,151,626 2019-08-01 0

GREGORY GINGER EVP, HUMAN RESOURCES

  • Officer
2,215 2019-08-01 2

KOPPEL ADAM

  • Director
3,871,164 2019-07-30 0

CLANCY PAUL J EVP, CHIEF FINANCIAL OFFICER

  • Officer
90,447 2019-07-11 0

KARABOUTIS ADRIANA

  • Director
5,427 2019-07-05 0

KARP DANIEL EVP, CORPORATE DEVELOPMENT

  • Officer
264 2019-07-02 2

SCHENK LYNN

  • Director
0 2019-07-01 2

SHARP PHILIP A

  • Director
0 2019-07-01 0

DENNER ALEXANDER J

  • Director
4,216,092 2019-06-28 3

HASLER HANS PETER

  • Director
10,000 2019-06-26 0

SHERWIN STEPHEN A

  • Director
0 2019-06-25 2

HASNAIN FAHEEM

  • Director
0 2019-06-25 0

GAGNON ROBERT E. CHIEF FINANCIAL OFFICER

  • Officer
151,000 2019-06-21 0

ROWINSKY ERIC K

  • Director
0 2019-06-21 1

POSNER BRIAN S

  • Director
8,050 2019-06-19 2

LEAMING NANCY

  • Director
12,098 2019-06-19 1

PANGIA ROBERT W

  • Director
19,742 2019-06-19 2

DORSA CAROLINE

  • Director
20,207 2019-06-19 1

PAPADOPOULOS STELIOS

  • Director
33,301 2019-06-19 1

MULLIGAN RICHARD

  • Director
12,064 2019-06-19 1

MANTAS JESUS B

  • Director
1,155 2019-06-19 2

HAWKINS WILLIAM A

  • Director
1,155 2019-06-19 2

YOUNG WILLIAM

  • Director
0 2019-06-18 0

MULLEN JAMES C

  • Director
0 2019-06-12 0

WILLIAMS DOUGLAS E

  • Director
0 2019-06-10 0

EHLERS MICHAEL D EVP, RESEARCH AND DEVELOPMENT

  • Officer
8,025 2019-06-01 4

SANDROCK ALFRED

  • Director
0 2019-05-22 3

COX JOHN

  • Director
7,236 2019-05-15 0

VOUNATSOS MICHEL CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
21,829 2019-05-02 4

ALEXANDER SUSAN H

  • Director
36,198 2019-03-15 3

MCKENZIE PAUL EVP PHARMACEUTICAL OPER & TECH

  • Officer
7,235 2019-03-01 3

GUINDO CHIRFI EVP GLOB. MKT ACC & CUST INNOV

  • Officer
0 2019-02-12 2

CAPELLO JEFFREY D EVP & CHIEF FINANCIAL OFFICER

  • Officer
0 2019-02-12 2

KRAMER ROBIN VP, CHIEF ACCOUNTING OFFICER

  • Officer
0 2019-02-12 3

DUNN JOHN MICHAEL

  • Director
0 2019-02-01 0

COVINO GREGORY F SVP, CAO, PAO

  • Officer
0 2019-01-22 0

MACLEAN MICHAEL F CHIEF FINANCIAL OFFICER

  • Officer
0 2019-01-02 0

BEST LAWRENCE C

  • Director
49,103 2018-11-29 0

KINGSLEY STUART A

  • Director
0 2018-06-08 0

DIPIETRO KENNETH

  • Director
0 2018-01-19 0

SCHNEIER CRAIG ERIC EVP AND CHIEF TALENT OFFICER

  • Officer
No longer subject to file 2017-08-29 0

KRESS JEAN-PAUL EVP PRES INT'L & GLOBAL HD GTO

  • Officer
0 2017-07-03 0

PICKETT CECIL B

  • Director
0 2017-05-12 0

LYTTON MICHAEL EVP, CORP DEVELOPMENT & STRTGY

  • Officer
386,292 2016-07-20 0

ARTAVANIS-TSAKONAS SPYRIDON EVP, CHIEF SCIENTIFIC OFFICER

  • Officer
3,150 2016-04-02 0

HOLTZMAN STEVEN H EVP CORPORATE DEVELOPMENT

  • Officer
No longer subject to file 2016-02-23 0

PAWLICKI RAYMOND SVP, CHIEF INFORMATION OFFICER

  • Officer
8,710 2013-11-22 0

GRANATA FRANCESCO EVP GLOBAL COMMERCIAL OPERATIO

  • Officer
3,529 2012-02-01 0

ROSS BRUCE

  • Director
No longer subject to file 2010-06-08 0

HAMM ROBERT A CHIEF OPERATING OFFICER

  • Officer
27,212 2010-04-23 0

KELLER THOMAS F

  • Director
No longer subject to file 2008-09-29 0

GLASSBERG ALAN

  • Director
5,600 2008-06-19 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

GREGORY GINGER - Officer EVP, HUMAN RESOURCES

2019-08-01 J 247 d 428 2,215.00 direct

GREGORY GINGER - Officer EVP, HUMAN RESOURCES

2019-08-01 M 179 a 2,295 2,215.00 direct

GREGORY GINGER - Officer EVP, HUMAN RESOURCES

2019-08-01 M 179 d 675 2,215.00 direct

GREGORY GINGER - Officer EVP, HUMAN RESOURCES

2019-08-01 F 128 $243.06 d 2,116 2,215.00 direct

GREGORY GINGER - Officer EVP, HUMAN RESOURCES

2019-08-01 F 80 $243.06 d 2,215 2,215.00 direct

KARP DANIEL - Officer EVP, CORPORATE DEVELOPMENT

2019-07-02 M 196 a 322 264.39 direct

KARP DANIEL - Officer EVP, CORPORATE DEVELOPMENT

2019-07-02 M 196 d 1,564 264.39 direct

KARP DANIEL - Officer EVP, CORPORATE DEVELOPMENT

2019-07-02 F 58 $236.37 d 264 264.39 direct

KARP DANIEL - Officer EVP, CORPORATE DEVELOPMENT

2019-07-02 J 390 d 1,174 264.39 direct
Click here to report any possible errors with this stock listing.

Elevate your investments